TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alzamend Neuro ( (ALZN) ) just unveiled an announcement.
Alzamend Neuro, Inc. announced the passing of Andrew H. Woo, M.D., Ph.D., a director who had been with the company since its initial public offering in June 2021. His death on November 14, 2025, marks a significant loss for the company, as he was a valued member of the Board of Directors, providing exceptional inspiration and friendship to his colleagues.
The most recent analyst rating on (ALZN) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on Alzamend Neuro stock, see the ALZN Stock Forecast page.
More about Alzamend Neuro
Average Trading Volume: 114,704
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.97M
Learn more about ALZN stock on TipRanks’ Stock Analysis page.